Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Burton

Showing results (581-590 of 649) with videos related to

Pageof 65
Sort By:
The American Surgeon|February 23, 2011
Prognostic significance of tumor infiltrating lymphocytes in melanomaAlison L Burton, Brent A Roach, Michael P Mays, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 29, 2012
Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trialCarol L Armour, Helen K Reddel, Kate S LeMay, et al.
Eye (London, England)|May 12, 2025
Visual outcome following initiation of first injection versus after three monthly doses of aflibercept 2 mg for treatment naïve age-related macular degeneration to inform clinical trial designs: PRECISE Report No. 6Swati Chandak, Sarega Gurudas, Raheeba Pakeer Muhammed, et al.
Molecular Cancer Research : MCR|January 20, 2012
The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cellsDat T Vo, Kotb Abdelmohsen, Jennifer L Martindale, et al.
The Journal of Infectious Diseases|August 12, 2025
Low intrinsic killing activity and no impact of its positivity on phase 3 pneumococcal vaccine adult studiesWeifeng Xu, Joseph Antonello, Jennifer Nguyen, et al.
Investigative Ophthalmology & Visual Science|November 1, 2011
Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae KeratitisErin W Norcross, Melissa E Sanders, Quincy C Moore, et al.
Biological Psychiatry|August 19, 2018
Polygenic Risk and Neural Substrates of Attention-Deficit/Hyperactivity Disorder Symptoms in Youths With a History of Mild Traumatic Brain InjurySonja Stojanovski, Daniel Felsky, Joseph D Viviano, et al.
Eye (London, England)|May 6, 2024
Impact of treat and extend criteria on proportions that can be extended after loading phase of 2 mg aflibercept therapy for neovascular age related macular degeneration: PRECISE Report 5Sridevi Thottarath, Sarega Gurudas, Swati Chandak, et al.
BMC Public Health|August 11, 2019
Project ESTEEM protocol: a randomized controlled trial of an LGBTQ-affirmative treatment for young adult sexual minority men's mental and sexual healthJohn E Pachankis, Erin M McConocha, Jesse S Reynolds, et al.
Frontiers in Pharmacology|January 23, 2023
Expanding the toolbox of metabolically stable lipid prodrug strategiesKiran S Toti, Nicole Pribut, Michael D'Erasmo, et al.
Pageof 65

Showing results (581-590 of 649) with videos related to

Sort By:
Pageof 65
The American Surgeon|February 23, 2011
Prognostic significance of tumor infiltrating lymphocytes in melanomaAlison L Burton, Brent A Roach, Michael P Mays, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|December 29, 2012
Feasibility and effectiveness of an evidence-based asthma service in Australian community pharmacies: a pragmatic cluster randomized trialCarol L Armour, Helen K Reddel, Kate S LeMay, et al.
Eye (London, England)|May 12, 2025
Visual outcome following initiation of first injection versus after three monthly doses of aflibercept 2 mg for treatment naïve age-related macular degeneration to inform clinical trial designs: PRECISE Report No. 6Swati Chandak, Sarega Gurudas, Raheeba Pakeer Muhammed, et al.
Molecular Cancer Research : MCR|January 20, 2012
The oncogenic RNA-binding protein Musashi1 is regulated by HuR via mRNA translation and stability in glioblastoma cellsDat T Vo, Kotb Abdelmohsen, Jennifer L Martindale, et al.
The Journal of Infectious Diseases|August 12, 2025
Low intrinsic killing activity and no impact of its positivity on phase 3 pneumococcal vaccine adult studiesWeifeng Xu, Joseph Antonello, Jennifer Nguyen, et al.
Investigative Ophthalmology & Visual Science|November 1, 2011
Active Immunization with Pneumolysin versus 23-Valent Polysaccharide Vaccine for Streptococcus pneumoniae KeratitisErin W Norcross, Melissa E Sanders, Quincy C Moore, et al.
Biological Psychiatry|August 19, 2018
Polygenic Risk and Neural Substrates of Attention-Deficit/Hyperactivity Disorder Symptoms in Youths With a History of Mild Traumatic Brain InjurySonja Stojanovski, Daniel Felsky, Joseph D Viviano, et al.
Eye (London, England)|May 6, 2024
Impact of treat and extend criteria on proportions that can be extended after loading phase of 2 mg aflibercept therapy for neovascular age related macular degeneration: PRECISE Report 5Sridevi Thottarath, Sarega Gurudas, Swati Chandak, et al.
BMC Public Health|August 11, 2019
Project ESTEEM protocol: a randomized controlled trial of an LGBTQ-affirmative treatment for young adult sexual minority men's mental and sexual healthJohn E Pachankis, Erin M McConocha, Jesse S Reynolds, et al.
Frontiers in Pharmacology|January 23, 2023
Expanding the toolbox of metabolically stable lipid prodrug strategiesKiran S Toti, Nicole Pribut, Michael D'Erasmo, et al.
Pageof 65